What is the recommended treatment for progressive L4‑5 listhesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Progressive L4-5 Listhesis

For progressive L4-5 degenerative spondylolisthesis with stenosis, decompression combined with posterolateral fusion (PLF) is the recommended treatment, achieving 96% good-to-excellent outcomes compared to only 44% with decompression alone. 1

Surgical Approach Algorithm

Primary Recommendation: Decompression + Fusion

The evidence strongly supports fusion at the time of decompression for L4-5 listhesis with stenosis. The landmark Herkowitz and Kurz study demonstrated that patients undergoing decompression with noninstrumented PLF had:

  • 96% excellent/good outcomes vs. 44% with decompression alone
  • Significantly less back pain (p=0.01) and leg pain (p=0.002)
  • Prevention of progressive spinal deformity 1

This represents Class II medical evidence and forms the foundation of guideline recommendations 1.

Fusion Technique Selection

Posterolateral fusion (PLF) is the standard approach for L4-5 degenerative spondylolisthesis. The evidence shows:

  • PLF alone: 90% good/excellent results 1
  • PLF with interbody techniques: No significant outcome differences at 4-year follow-up, but PLF alone associated with lower reoperation rates (6% vs. 28% for PLF+TLIF at 8.7 years) 2

Add pedicle screw instrumentation when:

  • Preoperative instability is documented (>2mm translation on flexion-extension films)
  • Kyphosis exists at the listhesis level
  • Iatrogenic instability is anticipated from extensive facetectomy 1

Critical Technical Considerations

Preserve facet joint integrity during decompression. Studies demonstrate outcome stratification based on facet preservation:

  • Decompression + PLF: 90% good/excellent
  • Decompression with facet preservation: 80% good/excellent
  • Decompression with facetectomy: Only 33% good/excellent 1

This highlights that iatrogenic instability from aggressive facetectomy significantly worsens outcomes and mandates fusion 1.

When Decompression Alone May Be Considered

Recent evidence suggests decompression alone can be considered in highly selected cases where fusion is contraindicated:

  • Advanced age (mean 69 years in one cohort)
  • Significant medical comorbidities
  • Patient preference against fusion
  • Preserved facet joint integrity maintained during surgery 3

However, this approach requires:

  • Minimal preoperative instability (<2mm on flexion-extension)
  • Strict preservation of pars interarticularis and facet joints
  • Patient counseling about higher failure rates 4

The 2025 data shows decompression alone can achieve comparable short-term outcomes in unstable listhesis when fusion cannot be performed, but this represents preliminary evidence requiring longer follow-up 3.

Common Pitfalls to Avoid

  1. Performing decompression alone in the presence of documented instability - This leads to progression of deformity and poor outcomes 1

  2. Aggressive facetectomy without fusion - Creates iatrogenic instability with only 33% satisfactory results 1

  3. Assuming interbody techniques are superior - No functional outcome advantage demonstrated, with potentially higher reoperation rates 5, 2

  4. Ignoring preoperative flexion-extension radiographs - Essential for documenting instability and guiding fusion decision 4

Evidence Strength Summary

The recommendation for decompression + fusion is supported by:

  • Class II evidence from prospective alternating assignment studies 1
  • Multiple Class III studies consistently showing 80-96% good outcomes with fusion vs. 44-78% without 1
  • 93% patient satisfaction in large multicenter observational trials 1

The guideline designation is "Recommended" rather than optional, reflecting the strength and consistency of evidence favoring fusion in this population 1.

Related Questions

What preoperative pain management regimen should be used for a patient with L4‑5 listhesis undergoing decompression‑fusion surgery, assuming no significant renal, hepatic, or gastrointestinal contraindications?
Explain moderate to severe effacement of the lateral recesses bilaterally at the L4‑5 level on MRI in terms a ninth‑grade student can understand.
What muscle relaxer can be given to a patient with recent L4-5 (lumbar 4-5) laminectomy and left leg Deep Vein Thrombosis (DVT) for back pain?
How should a posterior annular fibrosus tear at L5‑S1 be managed?
Should I refer the patient with advanced lumbar facet degenerative joint disease and minimal L4‑5 subluxation to an orthopedic spine surgeon for evaluation?
What is the recommended dosing regimen for nebivolol (Bystolic) for hypertension and heart failure, including dose adjustments for renal or hepatic impairment and in elderly patients?
In a preterm infant presenting with poor feeding, cyanosis, and a continuous machinery murmur consistent with patent ductus arteriosus, what is the most appropriate management: indomethacin or prostaglandin?
What troponin concentration indicates an acute myocardial infarction?
Which patients are candidates for pamidronate therapy?
In a newborn with weak femoral pulses and lower extremity blood pressure significantly lower than the upper extremities, what is the most appropriate test to confirm the diagnosis?
What preoperative pain management regimen should be used for a patient with L4‑5 listhesis undergoing decompression‑fusion surgery, assuming no significant renal, hepatic, or gastrointestinal contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.